Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

19 Apr 2011 07:00

RNS Number : 1280F
Microgen PLC
19 April 2011
 



microgen

www.microgen.com

 

19 April 2011

 

INTERIM MANAGEMENT STATEMENT

 

Ahead of the Company's Annual General Meeting later today, Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 January 2011 to the date of this announcement. Microgen released its final results for the year ending 31 December 2010 on 24 February 2011.

 

The Group's financial results for the three months ended 31 March 2011 are in line with the Board's expectations. There have been no significant changes in the trading or financial position of Microgen and its balance sheet remains strong. Microgen had cash at 31 March 2011 of £27.5 million (31 December 2010: £25.4 million) and net funds of £25.8 million (31 December 2010: £23.6 million), prior to the proposed dividend payment in May of £1.7 million.

 

The Microgen Aptitude Solutions Division has made a good start to the year continuing to deliver strong growth with a number of new licence agreements and extensions. The Financial Systems Division continues to perform satisfactorily in a flat market environment, underpinned by the Division's high recurring revenue and the Group's annual software licencing model.

 

Reflecting the evolution of his role, the Board has now promoted David Sherriff to Chief Executive Officer. Also, the Board has appointed Peter Bertram, who is currently a non-executive director and chairman of the audit committee, as the senior independent non-executive director.

 

While it is still early in the year and the Board remains cautious and prudent, Microgen has started the year well and remains on track to meet the Board's expectations.

 

 

Contacts

Martyn Ratcliffe, Chairman 01252-772300

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, Financial Dynamics 020-7831-3113

Haya Herbert-Burns, Financial Dynamics

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSIPMATMBABBJB
Date   Source Headline
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 202512:12 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 202512:17 pmRNSTotal Voting Rights
29th May 20257:00 amRNSShare Buyback Programme Renewal
28th May 202511:50 amRNSResult of Annual General Meeting
28th May 20257:00 amRNSAGM Statement and Board Appointment
23rd May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20252:47 pmRNSGrant of awards under the Aptitude 2020 DBP
1st May 202510:42 amRNSTotal Voting Rights
29th Apr 20257:00 amRNSNotice of 2025 Annual General Meeting
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20254:16 pmRNSExercise of awards under the Aptitude 2020 DBP
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSAptitude Fynapse New Contract Win
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202511:49 amRNSTotal Voting Rights
31st Mar 202510:29 amRNSNotification of Major Holdings
31st Mar 202510:11 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20255:01 pmRNSNotification of Major Holdings
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20255:10 pmRNSDirectorate Change
26th Mar 20257:00 amRNSAudited Results for Year Ended 31 December 2024
20th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20258:46 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.